Later, with advances in detection approaches, such as chromosomal comparative genomic hybridization, two-dimensional electrophoresis coupled with MALDI–TOF-MS and quantitative PCR, the upregulation of EEF1D was described by several researchers in other cancers like esophageal carcinomas [9], non-small-cell lung cancers [10], and medulloblastomas [11]. The gene discussed is EEF1D; the disease is cancer.